Skip to content
The Nexus
DossierENTITY

zovegalisib

Coverage of zovegalisib in the Nexus archive.

Earliest in view: May 19 · 13:55 UTCMost recent: May 19 · 13:55 UTC
Co-mentioned in this coverage
Eli Lillyorganization1Relay Therapeuticsorganization1IDEA Pharmaorganization1San Franciscoplace1
Recent coverage
  • HEALTHMay 19 · 13:55 UTCSTAT NEWS
    STAT+: A new ranking of pharma companies by R&D performance

    Eli Lilly ranked first in two categories for R&D performance, while Relay Therapeutics reported promising Phase 2 data for its drug zovegalisib. This led to a 9% increase in company shares during premarket trading. IDEA Pharma conducts the annual ranking of pharma companies.